Brief: Adial Pharma Confirms Scheduling Of Meetings With FDA, European Regulatory Agencies Reg AD04

Adial Pharmaceuticals

21/02/2023 14:03

Feb 21 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS CONFIRMS SCHEDULING OF MEETINGS WITH
FDA
AND EUROPEAN REGULATORY AGENCIES TO ADVANCE CLINICAL DEVELOPMENT
OF AD04 FOR ALCOHOL USE DISORDER
    * ADIAL PHARMACEUTICALS INC: TYPE C MEETING WITH FDA SET FOR
Q2
    * ADIAL PHARMACEUTICALS INC: PLANS IN PLACE TO MEET WITH
MULTIPLE
REGULATORY AGENCIES THROUGHOUT EUROPE

Source text for Eikon:  ID:nGNXbCWy0d 
Further company coverage:  ADIL.O 
 ((Reuters.Briefs@thomsonreuters.com;))